Skip to content
HowShorted

ARS Pharmaceuticals, Inc. short interest in 2026

In 2026, ARS Pharmaceuticals, Inc.'s disclosed short interest ran from 20.46% of shares outstanding on 15 Jan 2026 to 23.20% on 15 Sep 2026, a change of +2.74 percentage points. The year's high was 26.95% on 15 Apr 2026 and its low 20.46% on 15 Jan 2026, averaging 23.61% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 32.31 days on 27 Feb 2026. Full history: ARS Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ARS Pharmaceuticals, Inc. in 2026

2026 in figures

Start of year
20.46% (15 Jan 2026)
End of year
23.20% (15 Sep 2026)
Change
+2.74 pp
High
26.95% (15 Apr 2026)
Low
20.46% (15 Jan 2026)
Average
23.61%
Highest days to cover
32.31 (27 Feb 2026)
SEC filings marked
6

Every report in 2026

ARS Pharmaceuticals, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202620.46%9.35
30 Jan 202621.65%15.19
13 Feb 202622.50%18.41
27 Feb 202623.02%32.31
13 Mar 202623.89%17.9010-K filed, results (8-K)
31 Mar 202625.52%13.89
15 Apr 202626.95%21.22
30 Apr 202626.38%15.13
15 May 202626.10%13.3010-Q filed, results (8-K)
29 May 202625.68%14.08
15 Jun 202623.25%17.61
30 Jun 202621.89%8.55
15 Jul 202622.83%15.30
31 Jul 202621.60%7.78
14 Aug 202623.08%11.0310-Q filed, results (8-K)
31 Aug 202623.34%14.14
15 Sep 202623.20%15.51

See also: ARS Pharmaceuticals, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.